Linghao Bu

No.79 Qingchun Road
Hangzhou, 310003, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Retraction: Safety and Efficacy of Anlotinib Hydrochloride Plus Temozolomide in Patients with Recurrent Glioblastoma.

Retraction: Safety and Efficacy of Anlotinib Hydrochloride Plus Temozolomide in Patients with Recurrent Glioblastoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: March 17, 2026

DENND2D serves as a novel prognostic biomarker with paradoxical protumorigenic effects in glioma.

DENND2D serves as a novel prognostic biomarker with paradoxical protumorigenic effects in glioma.

Journal: Discover oncology

Published: July 13, 2025

A Language Performance Model for Predicting Glioma Recurrence and Molecular Biomarkers: A Retrospective Cohort Study.

A Language Performance Model for Predicting Glioma Recurrence and Molecular Biomarkers: A Retrospective Cohort Study.

Journal: Brain and behavior

Published: July 07, 2025

Hydrocephalus in primary brainstem hemorrhage risk predictors and management.

Hydrocephalus in primary brainstem hemorrhage risk predictors and management.

Journal: Scientific reports

Published: November 18, 2024

Primary solitary pituitary stalk abscess: case report and review.

Primary solitary pituitary stalk abscess: case report and review.

Journal: Frontiers in endocrinology

Published: October 13, 2024

Nonenhancing Margin and Pial Invasion in Magnetic Resonance Imaging can Predict Isocitrate Dehydrogenase Status in Glioma Patients.

Nonenhancing Margin and Pial Invasion in Magnetic Resonance Imaging can Predict Isocitrate Dehydrogenase Status in Glioma Patients.

Journal: World neurosurgery

Published: September 18, 2024

Recursive partitioning analysis for survival stratification and early imaging prediction of molecular biomarker in glioma patients.

Recursive partitioning analysis for survival stratification and early imaging prediction of molecular biomarker in glioma patients.

Journal: BMC cancer

Published: March 03, 2024

Decoding and synthesizing tonal language speech from brain activity.

Decoding and synthesizing tonal language speech from brain activity.

Journal: Science advances

Published: June 09, 2023

RETRACTED: Safety and Efficacy of Anlotinib Hydrochloride Plus Temozolomide in Patients with Recurrent Glioblastoma.

RETRACTED: Safety and Efficacy of Anlotinib Hydrochloride Plus Temozolomide in Patients with Recurrent Glioblastoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: February 18, 2023

A speech fluency brain network derived from gliomas.

A speech fluency brain network derived from gliomas.

Journal: Brain communications

Published: January 12, 2023

Germline ALK variations are associated with a poor prognosis in glioma and IDH-wildtype glioblastoma.

Germline ALK variations are associated with a poor prognosis in glioma and IDH-wildtype glioblastoma.

Journal: Journal of neuro-oncology

Published: October 07, 2020

Intraoperative Cognitive Mapping Tasks for Direct Electrical Stimulation in Clinical and Neuroscientific Contexts.

Intraoperative Cognitive Mapping Tasks for Direct Electrical Stimulation in Clinical and Neuroscientific Contexts.

Journal: Frontiers in human neuroscience

Published: October 01, 2020

Showing 1-12 of 14

Last Updated: 09/26/2026